490 related articles for article (PubMed ID: 26838793)
1. A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.
Hu X; Xu Y; Zhong Z; Wu Y; Zhao J; Wang Y; Cheng H; Kong M; Zhang F; Chen Q; Sun J; Li Q; Jin J; Li Q; Chen L; Wang C; Zhan H; Fan Y; Yang Q; Yu L; Wu R; Liang J; Zhu J; Wang Y; Jin Y; Lin Y; Yang F; Jia L; Zhu W; Chen J; Yu H; Zhang J; Wang J
Circ Res; 2016 Mar; 118(6):970-83. PubMed ID: 26838793
[TBL] [Abstract][Full Text] [Related]
2. Fortune Favors the Prepared: Safety and Efficacy of Allogeneic Hypoxia Preconditioned Mesenchymal Stromal Cells in Primates.
Kuster GM; Liao R
Circ Res; 2016 Mar; 118(6):908-10. PubMed ID: 26987910
[No Abstract] [Full Text] [Related]
3. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
4. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
Hu X; Yu SP; Fraser JL; Lu Z; Ogle ME; Wang JA; Wei L
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
[TBL] [Abstract][Full Text] [Related]
7. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
[TBL] [Abstract][Full Text] [Related]
8. Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells.
Wang JA; He A; Hu X; Jiang Y; Sun Y; Jiang J; Gui C; Wang Y; Chen H
Int J Cardiol; 2009 Apr; 133(3):410-2. PubMed ID: 18234368
[TBL] [Abstract][Full Text] [Related]
9. Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts.
Yao Y; Huang J; Geng Y; Qian H; Wang F; Liu X; Shang M; Nie S; Liu N; Du X; Dong J; Ma C
PLoS One; 2015; 10(6):e0129164. PubMed ID: 26043119
[TBL] [Abstract][Full Text] [Related]
10. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
[TBL] [Abstract][Full Text] [Related]
11. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
15. Non-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells.
Karpov AA; Puzanov MV; Ivkin DY; Krasnova MV; Anikin NA; Docshin PM; Moiseeva OM; Galagudza MM
Int J Exp Pathol; 2019 Apr; 100(2):102-113. PubMed ID: 31017330
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
[TBL] [Abstract][Full Text] [Related]
17. Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection.
Zhang Y; Chiu S; Liang X; Chai YH; Qin Y; Wang J; Li X; Qiu B; Tergaonkar V; Tse HF; Lian Q
Exp Cell Res; 2017 Jul; 356(1):74-84. PubMed ID: 28412246
[TBL] [Abstract][Full Text] [Related]
18. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance.
Zeng B; Chen H; Zhu C; Ren X; Lin G; Cao F
Eur J Cardiothorac Surg; 2008 Oct; 34(4):850-6. PubMed ID: 18640847
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
Xie X; Sun A; Zhu W; Huang Z; Hu X; Jia J; Zou Y; Ge J
Tohoku J Exp Med; 2012 Jan; 226(1):29-36. PubMed ID: 22186034
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
